Understand Central Compartment Atopic Disease (2023 AMW)
2023 AAO-HNSF Annual Meeting & OTO Experience
Central Compartment Atopic Disease is a recently described subtype of Chronic Rhinosinusitis with Nasal Polyposis. At first, it was noted that some types of polypoid degeneration of the middle turbinate were closely associated with inhalant allergic disease and that some types of more advanced manifestations involving sinonasal polyposis of the entire central nasal cavity were as well. It has now become recognized as its own phenotypic variant of CRSwNP. A specific pattern of endoscopic and computerized tomography findings is associated with CCAD. Given its association with inhalant allergy, it may be that a different approach to treatment may be necessary. This panel of experts will discuss what CCAD is and how it came to be recognized as its own phenotypic entity, the inhalant allergy driving this inflammatory process, and what role surgery and immunotherapy play in its treatment. Could FESS worsen disease progression? Should immunotherapy be used as primary treatment? Would a biologic be the best choice for patients with this subtype?
Credits
CME:1.0, MOC:1.0